These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 21266531)

  • 1. The ATP-binding cassette transporter ABCB6 is induced by arsenic and protects against arsenic cytotoxicity.
    Chavan H; Oruganti M; Krishnamurthy P
    Toxicol Sci; 2011 Apr; 120(2):519-28. PubMed ID: 21266531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium arsenite induced reactive oxygen species generation, nuclear factor (erythroid-2 related) factor 2 activation, heme oxygenase-1 expression, and glutathione elevation in Chang human hepatocytes.
    Li B; Li X; Zhu B; Zhang X; Wang Y; Xu Y; Wang H; Hou Y; Zheng Q; Sun G
    Environ Toxicol; 2013 Jul; 28(7):401-10. PubMed ID: 21809430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of long isoforms of Nfe2l1 sensitizes MIN6 pancreatic β cells to arsenite-induced cytotoxicity.
    Cui Q; Fu J; Hu Y; Li Y; Yang B; Li L; Sun J; Chen C; Sun G; Xu Y; Zhang Q; Pi J
    Toxicol Appl Pharmacol; 2017 Aug; 329():67-74. PubMed ID: 28549828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2,3,5,6-Tetramethylpyrazine (TMP) down-regulated arsenic-induced heme oxygenase-1 and ARS2 expression by inhibiting Nrf2, NF-κB, AP-1 and MAPK pathways in human proximal tubular cells.
    Gong X; Ivanov VN; Hei TK
    Arch Toxicol; 2016 Sep; 90(9):2187-2200. PubMed ID: 26404762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity.
    Wang XJ; Sun Z; Chen W; Eblin KE; Gandolfi JA; Zhang DD
    Toxicol Appl Pharmacol; 2007 Dec; 225(2):206-13. PubMed ID: 17765279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium arsenite induces cyclooxygenase-2 expression in human uroepithelial cells through MAPK pathway activation and reactive oxygen species induction.
    Wang H; Xi S; Xu Y; Wang F; Zheng Y; Li B; Li X; Zheng Q; Sun G
    Toxicol In Vitro; 2013 Apr; 27(3):1043-8. PubMed ID: 23376440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetramethylpyrazine (TMP) protects against sodium arsenite-induced nephrotoxicity by suppressing ROS production, mitochondrial dysfunction, pro-inflammatory signaling pathways and programed cell death.
    Gong X; Ivanov VN; Davidson MM; Hei TK
    Arch Toxicol; 2015 Jul; 89(7):1057-70. PubMed ID: 24961358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Nrf2 deficiency on arsenic metabolism in mice.
    Wang H; Zhu J; Li L; Li Y; Lv H; Xu Y; Sun G; Pi J
    Toxicol Appl Pharmacol; 2017 Dec; 337():111-119. PubMed ID: 29108910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2 protects against As(III)-induced damage in mouse liver and bladder.
    Jiang T; Huang Z; Chan JY; Zhang DD
    Toxicol Appl Pharmacol; 2009 Oct; 240(1):8-14. PubMed ID: 19538980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-isoform NRF1 protects against arsenic cytotoxicity in mouse bone marrow-derived mesenchymal stem cells by suppressing mitochondrial ROS and facilitating arsenic efflux.
    Lou B; Hu Y; Lu X; Zhang X; Li Y; Pi J; Xu Y
    Toxicol Appl Pharmacol; 2020 Nov; 407():115251. PubMed ID: 32980394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous activation of Nrf2 and its target antioxidant enzymes leads to arsenite-induced malignant transformation of human bronchial epithelial cells.
    Yang X; Wang D; Ma Y; Xu X; Zhu Z; Wang X; Deng H; Li C; Chen M; Tong J; Yamanaka K; An Y
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):231-9. PubMed ID: 26420645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic responsive microRNAs in vivo and their potential involvement in arsenic-induced oxidative stress.
    Ren X; Gaile DP; Gong Z; Qiu W; Ge Y; Zhang C; Huang C; Yan H; Olson JR; Kavanagh TJ; Wu H
    Toxicol Appl Pharmacol; 2015 Mar; 283(3):198-209. PubMed ID: 25625412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative DNA damage enhances the carcinogenic potential of in vitro chronic arsenic exposures.
    Bach J; Peremartí J; Annangi B; Marcos R; Hernández A
    Arch Toxicol; 2016 Aug; 90(8):1893-905. PubMed ID: 26438402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrf2-dependent protection against acute sodium arsenite toxicity in zebrafish.
    Fuse Y; Nguyen VT; Kobayashi M
    Toxicol Appl Pharmacol; 2016 Aug; 305():136-142. PubMed ID: 27306194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol enhances arsenic-induced cyclooxygenase-2 expression via both NFAT and NF-κB signalings in colorectal cancer cells.
    Wang L; Hitron JA; Wise JT; Son YO; Roy RV; Kim D; Dai J; Pratheeshkumar P; Zhang Z; Xu M; Luo J; Shi X
    Toxicol Appl Pharmacol; 2015 Oct; 288(2):232-9. PubMed ID: 26220687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular changes during arsenic-induced cell transformation.
    Li G; Lee LS; Li M; Tsao SW; Chiu JF
    J Cell Physiol; 2011 Dec; 226(12):3225-32. PubMed ID: 21344382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linking arsenite- and cadmium-generated oxidative stress to microsatellite instability in vitro and in vivo.
    Wu CL; Huang LY; Chang CL
    Free Radic Biol Med; 2017 Nov; 112():12-23. PubMed ID: 28690196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium arsenite-induced myocardial bruise in rats: Ameliorative effect of naringin via TGF-β/Smad and Nrf/HO pathways.
    Adil M; Kandhare AD; Ghosh P; Bodhankar SL
    Chem Biol Interact; 2016 Jun; 253():66-77. PubMed ID: 27174133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of hepatocyte nuclear factor 1 and 4 alpha (HNF1α and HNF4α) as a mechanism of arsenic carcinogenesis.
    Pastoret A; Marcos R; Sampayo-Reyes A; Saucedo-Cardenas O; Lozano-Garza GH; Hernandez A
    Arch Toxicol; 2013 Jun; 87(6):1001-12. PubMed ID: 23052196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nrf2 deficiency aggravates the increase in osteoclastogenesis and bone loss induced by inorganic arsenic.
    Liu Z; Hou Y; Li L; Yang Y; Jia J; Hong Z; Li T; Xu Y; Fu J; Sun Y; Yamamoto M; Wang H; Pi J
    Toxicol Appl Pharmacol; 2019 Mar; 367():62-70. PubMed ID: 30742845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.